These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2558001
1. [Calcium channel as molecular target of drug action]. Taglialatela M, Annunziato L, Marino A. Clin Ter; 1989 Dec 15; 131(5):299-305. PubMed ID: 2558001 [Abstract] [Full Text] [Related]
4. [Pharmacological properties and use of calcium channel blockers]. Kostowski W, Obersztyn M. Pol Tyg Lek; 1984 Apr 15; 39(51-52):1701-5. PubMed ID: 6395120 [No Abstract] [Full Text] [Related]
5. Ca2+ channel subtypes and pharmacology in the kidney. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972 [Abstract] [Full Text] [Related]
6. [Pharmacological introduction to the clinical use of calcium antagonists]. Ferrari R, Boraso A, De Giuli F, Cargnoni A, Pasini E, Condorelli E, Boffa GM, Visioli O. G Ital Cardiol; 1988 Nov 16; 18(11):956-69. PubMed ID: 2854799 [No Abstract] [Full Text] [Related]
7. [Pharmacology of calcium antagonists]. Klaus W. Fortschr Med; 1984 Jul 26; 102(27-28):728-31. PubMed ID: 6479816 [Abstract] [Full Text] [Related]
8. [Cav channels and Ca2+ antagonists: recent advances in molecular characteristics and pharmacology]. Endoh M. Clin Calcium; 2006 Jan 26; 16(1):12-8. PubMed ID: 16397345 [Abstract] [Full Text] [Related]
10. Calcium-entry blockers: a review of their basic and clinical pharmacology and therapeutic applications. Schneck DW. Ration Drug Ther; 1985 May 26; 19(5):1-6. PubMed ID: 3903863 [No Abstract] [Full Text] [Related]
11. [Criteria of the clinical application of Ca++ antagonists]. Kishida H, Saito H, Hayakawa H. Nihon Rinsho; 1982 May 26; 40(11):2477-83. PubMed ID: 6218317 [No Abstract] [Full Text] [Related]
12. [Ion channels and arrhythmias]. Borchard U, Hafner D. Z Kardiol; 2000 May 26; 89 Suppl 3():6-12. PubMed ID: 10810780 [Abstract] [Full Text] [Related]
15. [Tissue selectivity of calcium channel blockers]. Godfraind T. C R Seances Soc Biol Fil; 1998 Nov 04; 192(1):121-35. PubMed ID: 9759358 [Abstract] [Full Text] [Related]
16. Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium. Cain BS, Meldrum DR, Cleveland JC, Meng X, Banerjee A, Harken AH. J Mol Cell Cardiol; 1999 Dec 04; 31(12):2191-7. PubMed ID: 10640446 [Abstract] [Full Text] [Related]
17. [Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists]. Adachi-Akahane S. Clin Calcium; 2005 Oct 04; 15(10):1589-97. PubMed ID: 16199903 [Abstract] [Full Text] [Related]
18. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists. Apostolakos MJ, Varon ME. New Horiz; 1996 Feb 04; 4(1):45-57. PubMed ID: 8689275 [Abstract] [Full Text] [Related]
19. Some similarities and differences between verapamil and the dihydropyridines. Antonios TF, MacGregor GA. J Hypertens Suppl; 1998 Jan 04; 16(1):S31-4. PubMed ID: 9534094 [Abstract] [Full Text] [Related]
20. [Calcium antagonists in cardiology]. Tullio D, Valerio A, D'Agostino F. Clin Ter; 1983 Jan 15; 104(1):27-51. PubMed ID: 6337771 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]